mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Summary of Evidence on Immediate Statins Therapy Following Aneurysmal Subarachnoid Hemorrhage

Tseng MY et al. – Effect on vasospasm was more difficult to determine, due to differences in definitions used among studies. Interpretations from observational studies were limited by the use of relatively small sample sizes, historical controls, and treatment variability.

Methods
  • This review consolidated data from available published studies evaluating statin treatment for subarachnoid hemorrhage.
  • Literature search was conducted to identify original research studies published through October 2010 testing immediate treatment with a statin in statin–naïve patients following aneurysmal SAH.
  • Six randomized controlled clinical trials and four observational studies were identified.

Results
  • Statins were shown to have neuroprotective effects, with reduced vasospasm and delayed ischemic deficits in statin–treated patients after aneurysmal subarachnoid hemorrhage in two small, randomized, controlled clinical trials published in 2005.
  • Despite inconsistent results among studies, a meta–analysis of randomized controlled data showed a significant reduction in delayed ischemic deficits with statins.
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close